New AMR Paper Explains Our Life-or-Death Battle with Superbugs and What We Need to Do to Win

The silent pandemic of antimicrobial resistance (AMR) is an under-recognized global health crisis that threatens the foundations of modern medicine.

New York, NEW YORK (February 17, 2022)—The Global Coalition on Aging (GCOA) today released a startling new paper, Wonder Drugs vs. Superbugs: The 21st Century Battle to Save 10 Million Lives a Year, which clearly lays out the global threat posed by rising drug resistance, widely known as antimicrobial resistance or AMR, and accompanying lack of effective new drugs. The paper, perhaps the first of its kind, asks us to imagine a world in which commonly used medicines no longer protect us from disease and suggests four steps for leaders in government, business, and across society to help avert this crisis. The paper was released alongside a series of regional infographics and Calls to Action on AMR for the United States, the European Union, and Japan. The paper and the infographic series were created with support from Pfizer.

Wonder Drugs vs. Superbugs follows the release last month of ground-breaking data on the global burden of AMR in The Lancet showing that AMR itself claimed 1.27 million lives in 2019 alone and contributed to nearly 5 million deaths that year. Beyond the loss of life, the new GCOA paper explains the stakes – a threat to the foundations of our healthcare systems, and even to the very premise of human longevity – if AMR continues unaddressed at its current pace, already accelerated by widespread infection and antibiotic use in the COVID-19 pandemic.

“AMR and the impact of our lack of new antibiotics pose an urgent and growing threat to the world that could soon eclipse that of the COVID-19 pandemic,” said Mike Hodin, CEO of the Global Coalition on Aging. “But those of us who know this have not done a good job at communicating what AMR is or what it means for us, our parents, and our children. This paper aims to correct this by clearly explaining the risk from AMR and what we, collectively and individually, can do about it,” said Hodin.

Germs evolve and many will develop into superbugs capable of evading the drugs we have developed to combat them. Once-defeated diseases are reemerging, and the rise of drug-resistant infections threatens a century of medical innovation. Worldwide, drug-resistant infections, which already killed 1.27 million people each year pre-COVID, are on track to claim an estimated 10 million lives each year by 2050.

As AMR grows, people with once-treatable conditions will be at greater risk of infection and even death. Relatively common surgeries, including cesarean sections, joint replacements, and organ transplants will become deadly, and many lives will be lost due to drug-resistant infections, including sepsis. Notably, the GCOA report was released alongside Sepsis Survivor Week.

The GCOA paper aims to highlight and elucidate the challenges of this silent and growing pandemic and calls on leaders to take four steps to bring needed attention to and action on AMR:

  • Reinvent and reimagine AMR to capture public attention
  • Broaden the audience to spur advocacy for new drugs
  • Establish right-size incentives to drive the discovery and development of new drugs
  • Adapt the COVID-19 model of collaboration for medical innovation

 

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Brazil Must Fight Antibiotic Resistance

The threat posed by antimicrobial resistance is urgent and spares no country - including Brazil. According to The Lancet, 63 deaths per 100,000 are associated with AMR in Brazil and Paraguay, a rate that exceeds the average for Latin America and the Caribbean. AMR-associated deaths in Brazil are second only to cardiovascular diseases and cancers.

We Missed 100 Million Adult Vaccines – Here’s How We Get Back on Track

Like other pandemics throughout human history, COVID-19 has caused profound changes that are still rippling through our societies, even as people are understandably eager to move on. In fact, these impacts are all the more dangerous when they are largely ignored or effectively invisible. The decline in adult vaccination may be one of the most significant, as a new report finds that ~100 million doses were missed in 2021 and 2022 alone – reversing global progress towards widespread adult immunisation as a new standard of care in a world of more old than young.

New Analysis Shows Lost Ground on Adult Immunisation During the Pandemic with 100 Million Doses Potentially Missed

New data shared today by GSK, in collaboration with the IQVIA Institute for Human Data Science and the Global Coalition on Aging (GCOA), estimate approximately 100 million fewer doses of some adult vaccines (excluding Covid-19 vaccines) were administered in 2021 and 2022 than anticipated, based on the global vaccination adoption trends observed from 2013 to 2020, compounding already low adoption rates pre-pandemic.

Going Beyond Applause: The Potential of Caregiving to Unlock Job Opportunities of the Future

Early in the COVID-19 pandemic, the role of caregivers – staff and family who provide care for older and dependent people to carry out activities such as eating or moving - catapulted to the front of our collective conscience. The daily applause for front-line care workers showed a high level of recognition for their incredible work and provided insight into how our health systems must change as our society ages. We need to continue to recognise caregivers as essential to our ageing society.

High-Level Forum on the Silver Economy 2023

Join us for the High-Level Forum on the Silver Economy 2023. Now in its fourth year, the Silver Economy Forum 2023, December 6 and 7, will explore aging at every stage of life, looking at the growing global Silver Economy through a multigenerational lens. Linking to the goals and aspirations of the UN Decade of Healthy Ageing, SEF 2023 will highlight key themes at the intersection of aging at every age, and the Silver Economy.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.